Found: 20
Select item for more details and to access through your institution.
Bevacizumab for Patients with Recurrent Multifocal Glioblastomas.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 11, p. 2469, doi. 10.3390/ijms18112469
- By:
- Publication type:
- Article
Bevacizumab for Patients with Recurrent Gliomas Presenting with a Gliomatosis Cerebri Growth Pattern.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 4, p. 726, doi. 10.3390/ijms18040726
- By:
- Publication type:
- Article
Molecular matched targeted therapies for primary brain tumors—a single center retrospective analysis.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 159, n. 2, p. 243, doi. 10.1007/s11060-022-04049-w
- By:
- Publication type:
- Article
Gliomatosis Cerebri Growth Pattern: Association of Differential First-Line Treatment with Overall Survival in WHO Grade II and III Gliomas.
- Published in:
- Oncology, 2021, v. 99, n. 4, p. 215, doi. 10.1159/000512562
- By:
- Publication type:
- Article
ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine.
- Published in:
- Oncology Letters, 2017, v. 14, n. 1, p. 1141, doi. 10.3892/ol.2017.6251
- By:
- Publication type:
- Article
AMPK activation protects astrocytes from hypoxia-induced cell death.
- Published in:
- International Journal of Molecular Medicine, 2020, v. 45, n. 5, p. 1385, doi. 10.3892/ijmm.2020.4528
- By:
- Publication type:
- Article
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial.
- Published in:
- Trials, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13063-021-05977-0
- By:
- Publication type:
- Article
Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma.
- Published in:
- Journal of Neurochemistry, 2018, v. 144, n. 4, p. 421, doi. 10.1111/jnc.14264
- By:
- Publication type:
- Article
Calcitriol Promotes Differentiation of Glioma Stem-Like Cells and Increases Their Susceptibility to Temozolomide.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3577, doi. 10.3390/cancers13143577
- By:
- Publication type:
- Article
Non-Invasive Measurement of Drug and 2-HG Signals Using 19 F and 1 H MR Spectroscopy in Brain Tumors Treated with the Mutant IDH1 Inhibitor BAY1436032.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3175, doi. 10.3390/cancers12113175
- By:
- Publication type:
- Article
Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death.
- Published in:
- Brain: A Journal of Neurology, 2009, v. 132, n. 6, p. 1509, doi. 10.1093/brain/awp093
- By:
- Publication type:
- Article
Local Anesthetic-Induced Central Nervous System Toxicity during Interscalene Brachial Plexus Block: A Case Series Study of Three Patients.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 5, p. 1013, doi. 10.3390/jcm10051013
- By:
- Publication type:
- Article
Ventriculoperitoneal Shunts Equipped with On-Off Valves for Intraventricular Therapies in Patients with Communicating Hydrocephalus due to Leptomeningeal Metastases.
- Published in:
- Journal of Clinical Medicine, 2018, v. 7, n. 8, p. 216, doi. 10.3390/jcm7080216
- By:
- Publication type:
- Article
CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy.
- Published in:
- Frontiers in Immunology, 2019, v. 10, p. 1, doi. 10.3389/fimmu.2019.02683
- By:
- Publication type:
- Article
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease.
- Published in:
- Oncology Reports, 2017, v. 38, n. 6, p. 3291, doi. 10.3892/or.2017.6013
- By:
- Publication type:
- Article
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 2058, doi. 10.1093/neuonc/noad087
- By:
- Publication type:
- Article
Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors.
- Published in:
- PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0155315
- By:
- Publication type:
- Article
Immunohistochemical Assessment of Phosphorylated mTORC1-Pathway Proteins in Human Brain Tumors.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0127123
- By:
- Publication type:
- Article